OneMedNet Short Interest Surges 45.8% in February

Shares of the medical imaging data company see increased short selling activity.

Mar. 2, 2026 at 9:39pm

Got story updates? Submit your updates here. ›

OneMedNet Corporation (NASDAQ:ONMD), a provider of clinical imaging solutions, saw a significant increase in short interest during the month of February. As of February 13th, short interest totaled 326,990 shares, up 45.8% from the January 29th total of 224,270 shares. This represents approximately 1.2% of the company's outstanding shares.

Why it matters

The rise in short interest could indicate that some investors are betting against OneMedNet's stock performance. Short selling activity can sometimes signal broader concerns about a company's outlook or fundamentals. However, increased short interest alone does not necessarily mean the stock will decline, as short sellers may ultimately be proven wrong.

The details

Based on OneMedNet's average daily trading volume of 283,072 shares, the current short interest ratio stands at 1.2 days. This means it would take short sellers just over a day to cover their positions at the current pace of trading. The company's stock has traded in a range of $0.30 to $4.22 over the past 52 weeks, closing at $1.02 on the most recent trading day.

  • As of February 13th, 2026, short interest totaled 326,990 shares.
  • On January 29th, 2026, short interest was 224,270 shares.

The players

OneMedNet Corporation

A provider of clinical imaging solutions that utilizes AI to securely manage and curate medical imaging data.

Weiss Ratings

A financial research firm that has maintained a "sell (d-)" rating on OneMedNet's stock.

Got photos? Submit your photos here. ›

The takeaway

The surge in short interest for OneMedNet's stock suggests some investors are bearish on the company's prospects, though the reasons behind this sentiment are not entirely clear. Continued monitoring of the stock's performance and any further developments around the short interest activity could provide more insight into the market's view of OneMedNet's business and outlook.